AR
CFN

Advisory Research’s CAREFUSION CORPORATION CFN Stock Holding History

Advisory Research’s Portfolio CFN Stock Details CFN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-1,702
Closed -$68K – 784
2014
Q1 		$68K Buy
+1,702
New +$68.9K ﹤0.01% 648

Other funds holding CFN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Advisory Research's CFN Position: Q2 2014 in Review

Advisory Research sold out of CAREFUSION CORPORATION (CFN) in Q2 2014, closing a stake of 1,702 shares — an estimated $68K sold.

Advisory Research first reported a position in CFN in Q1 2014 and held it in 1 quarter. The position peaked at $68K in Q1 2014. 419 funds tracked by Wall St. Rank hold CFN as of Q2 2014.

  • Advisory Research reported no remaining CAREFUSION CORPORATION position as of Q2 2014 after selling out during the quarter.
  • Advisory Research sold 1,702 CAREFUSION CORPORATION shares in Q2 2014, an estimated $68K.
  • Advisory Research first reported a position in CAREFUSION CORPORATION in Q1 2014 and held it in 1 quarter.
  • Advisory Research's CAREFUSION CORPORATION position peaked at $68K in Q1 2014.
  • 419 funds tracked by Wall St. Rank held CAREFUSION CORPORATION as of Q2 2014.

Based on Advisory Research's 13F filing for Q2 2014, filed 14 Aug 2014.